These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 25092654)

  • 41. Axonal activity-dependent myelination in development: Insights for myelin repair.
    Mitew S; Xing YL; Merson TD
    J Chem Neuroanat; 2016 Oct; 76(Pt A):2-8. PubMed ID: 26968658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibitory milieu at the multiple sclerosis lesion site and the challenges for remyelination.
    Galloway DA; Gowing E; Setayeshgar S; Kothary R
    Glia; 2020 May; 68(5):859-877. PubMed ID: 31441132
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced axonal response of mitochondria to demyelination offers neuroprotection: implications for multiple sclerosis.
    Licht-Mayer S; Campbell GR; Canizares M; Mehta AR; Gane AB; McGill K; Ghosh A; Fullerton A; Menezes N; Dean J; Dunham J; Al-Azki S; Pryce G; Zandee S; Zhao C; Kipp M; Smith KJ; Baker D; Altmann D; Anderton SM; Kap YS; Laman JD; Hart BA'; Rodriguez M; Watzlawick R; Schwab JM; Carter R; Morton N; Zagnoni M; Franklin RJM; Mitchell R; Fleetwood-Walker S; Lyons DA; Chandran S; Lassmann H; Trapp BD; Mahad DJ
    Acta Neuropathol; 2020 Aug; 140(2):143-167. PubMed ID: 32572598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Concurrent axon and myelin destruction differentiates X-linked adrenoleukodystrophy from multiple sclerosis.
    Bergner CG; Genc N; Hametner S; Franz J; van der Meer F; Mitkovski M; Weber MS; Stoltenburg-Didinger G; Kühl JS; Köhler W; Brück W; Gärtner J; Stadelmann C
    Glia; 2021 Oct; 69(10):2362-2377. PubMed ID: 34137074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pathogenesis and basis for treatment in multiple sclerosis.
    Compston A
    Clin Neurol Neurosurg; 2004 Jun; 106(3):246-8. PubMed ID: 15177777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Molecular Basis for Remyelination Failure in Multiple Sclerosis.
    Gruchot J; Weyers V; Göttle P; Förster M; Hartung HP; Küry P; Kremer D
    Cells; 2019 Aug; 8(8):. PubMed ID: 31382620
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions.
    Mews I; Bergmann M; Bunkowski S; Gullotta F; Brück W
    Mult Scler; 1998 Apr; 4(2):55-62. PubMed ID: 9599334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage.
    Pohl HB; Porcheri C; Mueggler T; Bachmann LC; Martino G; Riethmacher D; Franklin RJ; Rudin M; Suter U
    J Neurosci; 2011 Jan; 31(3):1069-80. PubMed ID: 21248132
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Axonal degeneration in demyelinating disorders.
    Madrid RE; Wiśniewski HM
    J Neurocytol; 1977 Feb; 6(1):103-17. PubMed ID: 839247
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neurodegeneration in multiple sclerosis and neuromyelitis optica.
    Kawachi I; Lassmann H
    J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):137-145. PubMed ID: 27671902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanisms of primary axonal damage in a viral model of multiple sclerosis.
    Das Sarma J; Kenyon LC; Hingley ST; Shindler KS
    J Neurosci; 2009 Aug; 29(33):10272-80. PubMed ID: 19692601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease.
    Schäffner E; Bosch-Queralt M; Edgar JM; Lehning M; Strauß J; Fleischer N; Kungl T; Wieghofer P; Berghoff SA; Reinert T; Krueger M; Morawski M; Möbius W; Barrantes-Freer A; Stieler J; Sun T; Saher G; Schwab MH; Wrede C; Frosch M; Prinz M; Reich DS; Flügel A; Stadelmann C; Fledrich R; Nave KA; Stassart RM
    Nat Neurosci; 2023 Jul; 26(7):1218-1228. PubMed ID: 37386131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
    Schultz V; van der Meer F; Wrzos C; Scheidt U; Bahn E; Stadelmann C; Brück W; Junker A
    Glia; 2017 Aug; 65(8):1350-1360. PubMed ID: 28560740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification of myelin and axon pathology during relapsing progressive experimental autoimmune encephalomyelitis in the Biozzi ABH mouse.
    Jackson SJ; Lee J; Nikodemova M; Fabry Z; Duncan ID
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):616-25. PubMed ID: 19458548
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial changes associated with demyelination: consequences for axonal integrity.
    Campbell GR; Mahad DJ
    Mitochondrion; 2012 Mar; 12(2):173-9. PubMed ID: 21406249
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Axonal loss in multiple sclerosis: causes and mechanisms.
    Criste G; Trapp B; Dutta R
    Handb Clin Neurol; 2014; 122():101-13. PubMed ID: 24507515
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
    Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
    Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
    McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
    J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.